Consolidated Statements of Cash Flow - USD ($) $ in Thousands	12 Months Ended
	Oct. 31, 2020	Oct. 31, 2019	Oct. 31, 2018
Operating activities:
Net (loss) income	$ 38,496	$ (46,730)	$ 26,553
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization	47,229	49,586	51,822
Loss (gain) on disposition of capital assets	0	732	(142)
Stock-based compensation	879	2,045	1,874
Deferred income tax	(189)	3,260	(5,556)
Noncash charge for deferred loan costs and debt discount	0	0	1,064
Asset impairment charges	0	74,600	0
Other, net	1,689	2,176	135
Changes in assets and liabilities, net of effects from acquisitions:
(Increase) decrease in accounts receivable	(5,766)	574	(5,550)
Decrease in inventory	6,119	3,797	17,230
Decrease (increase) in other current assets	2,896	(2,014)	217
Increase in accounts payable	15,922	8,124	8,325
(Decrease) increase in accrued liabilities	(3,156)	(6,760)	6,892
Increase in income taxes payable	237	3,416	676
(Decrease) increase in deferred pension and postretirement benefits	(2,775)	2,531	2,038
(Decrease) increase in other long-term liabilities	(236)	513	(523)
Other, net	(549)	522	(444)
Cash provided by operating activities	100,796	96,372	104,611
Investing activities:
Capital expenditures	(25,726)	(24,883)	(26,484)
Proceeds from disposition of capital assets	502	1,324	432
Cash used for investing activities	(25,224)	(23,559)	(26,052)
Financing activities:
Borrowings under credit facility	114,500	83,500	268,500
Repayments of credit facility borrowings	(154,000)	(136,000)	(296,250)
Debt issuance costs	0	0	(1,001)
Repayments of other long-term debt	(1,027)	(1,526)	(1,798)
Common stock dividends paid	(10,534)	(10,644)	(7,020)
Issuance of common stock	3,626	3,287	4,746
Payroll tax paid to settle shares forfeited upon vesting of stock	(454)	(330)	(960)
Purchase of treasury stock	(7,233)	(9,551)	(32,034)
Cash used for financing activities	(55,122)	(71,264)	(65,817)
Effect of exchange rate changes on cash and cash equivalents	303	316	(1,194)
Increase in cash and cash equivalents	20,753	1,865	11,548
Cash and cash equivalents at beginning of period	30,868	29,003	17,455
Cash and cash equivalents at end of period	$ 51,621	$ 30,868	$ 29,003